Archives: 2019-05-18

Liquid biopsy could identify cancer patients at risk of metastatic disease, offering an opportunity to tailor treatment

Researchers at The Royal Marsden say ctDNA, a form of liquid biopsy, may be an accurate technique to monitor treatment response in patients with locally advanced rectal cancer, allowing treatment to be adapted or changed earlier to try to prevent the development of metastatic disease.  Results from the study, led by researchers at The Royal

Read More


New strategy of reprogramming regulatory T cells may improve cancer therapies

While therapies that harness the power of the immune system against cancer have made remarkable progress against certain types of tumours, they still remain ineffective in most cancer patients. A new study has described a method of reprogramming the regulatory T cells that usually suppress immune responses into inflammatory cells that not only permit but

Read More


Adopting a healthy lifestyle helps reduce the risk of dementia

New WHO Guidelines recommend specific interventions for reducing the risk of cognitive decline and dementia People can reduce their risk of dementia by getting regular exercise, not smoking, avoiding harmful use of alcohol, controlling their weight, eating a healthy diet, and maintaining healthy blood pressure, cholesterol and blood sugar levels, according to new guidelines issued

Read More


RESTORE Large Scale Research Initiative New Fact Sheets and Presentation

Before Kick-off meeting in Berlin, RESTORE Community has published two important presentations which can be downloaded in the website and here we present and attach them. The first is a presentation of the Community Fact sheet. The second is a PowerPoint presentation. OVERVIEW Shifting from treating symptoms to curing chronic diseases by making the transformative

Read More


Preclinical Safety Study of a Combined Therapeutic Bone Wound Dressing for Osteoarticular Regeneration

Investigators tested the preclinical safety of the innovative implant ARTiCAR for the treatment of osteoarticular lesions. Thanks to the combination of two advanced therapy medicinal products, a polymeric nanofibrous bone wound dressing and bone marrow-derived mesenchymal stem cells, the ARTiCAR promoted both subchondral bone and cartilage regeneration. [Nat Commun] The extended life expectancy and the

Read More


Mesenchymal Stromal Cells Are Required for Regeneration and Homeostatic Maintenance of Skeletal Muscle

Researchers of the Stanford University College of Medicine have just published an important paper on FAP mesenchymal stromal cells in muscle regeneration. The necessity of mesenchymal stromal cells, called fibroadipogenic progenitors (FAPs), in skeletal muscle regeneration and maintenance remains unestablished. We report the generation of a PDGFRαCreER knockin mouse model that provides a specific means of

Read More


Targeting Huntingtin Expression and Gene Therapy in Patients with Huntington’s Disease

Data presented at the American Academy of Neurology (AAN) meeting this week on experimental therapeutics for Huntington’s disease gave some cause for optimism. And, as good research does, they identified new questions as they answered current ones. At the meeting, researchers presented new data on antisense oligonucleotide HTTRx (RG-6042, Ionis Pharmaceuticals Inc./Roche Holding AG) that

Read More